Pioneer Group: Investment Portfolio & Startup News
Pioneer Group
To add a bio or update investment portfolio click update information.
Investment Portfolio


NunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale
NunaBio develops an enzymatic DNA synthesis platform that manufactures high fidelity synthetic DNA at scale. The platform enables customers in sectors such as medicine, biotechnology and diagnostics to access complex DNA formats that are difficult to produce using traditional methods.


NuVision Biotherapies unlocks £4.8m in funding led by Mercia Ventures to speed up the healing of eye conditions
NuVision Biotherapies develops ophthalmic products based on amniotic membrane tissue. Its treatments are used to support healing after eye surgery and manage chronic eye conditions.


ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing
ImmuONE provides a 3D human lung laboratory model that replaces animal testing, allowing companies to assess respiratory safety, inflammation and long-term effects of chemicals, drugs and consumer products more reliably.
- 2(12 months)
- thepioneergroup.com
More venture news
- 13 Nov 2026

JADEJADE secures £450k in funding led by GC Angels to help universities manage their international student recruitment agents
EquityHR - 10 Nov 2026

PlankyPlanky raises £6m in funding co-led by Innovation Global and Azimut to turn financial data into credit decisions
EquityFintech - 10 Nov 2026

AncepAncep raises £6m in funding led by Creandum to help insurance brokers cover the clients they’d normally turn down
EquityEnterprise